STVN Strangle Strategy
STVN (Stevanato Group S.p.A.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
STVN (Stevanato Group S.p.A.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $4.88B, a trailing P/E of 29.53, a beta of 0.76 versus the broader market, a 52-week range of 12.89-28, average daily share volume of 605K, a public-listing history dating back to 2021, approximately 6K full-time employees. These structural characteristics shape how STVN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.76 places STVN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. STVN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on STVN?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current STVN snapshot
As of May 15, 2026, spot at $17.59, ATM IV 28.70%, IV rank 0.00%, expected move 8.23%. The strangle on STVN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on STVN specifically: STVN IV at 28.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a STVN strangle, with a market-implied 1-standard-deviation move of approximately 8.23% (roughly $1.45 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated STVN expiries trade a higher absolute premium for lower per-day decay. Position sizing on STVN should anchor to the underlying notional of $17.59 per share and to the trader's directional view on STVN stock.
STVN strangle setup
The STVN strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With STVN near $17.59, the first option leg uses a $18.47 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed STVN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 STVN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $18.47 | N/A |
| Buy 1 | Put | $16.71 | N/A |
STVN strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
STVN strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on STVN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on STVN
Strangles on STVN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the STVN chain.
STVN thesis for this strangle
The market-implied 1-standard-deviation range for STVN extends from approximately $16.14 on the downside to $19.04 on the upside. A STVN long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current STVN IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on STVN at 28.70%. As a Healthcare name, STVN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to STVN-specific events.
STVN strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. STVN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move STVN alongside the broader basket even when STVN-specific fundamentals are unchanged. Always rebuild the position from current STVN chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on STVN?
- A strangle on STVN is the strangle strategy applied to STVN (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With STVN stock trading near $17.59, the strikes shown on this page are snapped to the nearest listed STVN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are STVN strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the STVN strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 28.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a STVN strangle?
- The breakeven for the STVN strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current STVN market-implied 1-standard-deviation expected move is approximately 8.23%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on STVN?
- Strangles on STVN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the STVN chain.
- How does current STVN implied volatility affect this strangle?
- STVN ATM IV is at 28.70% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.